The Food and Drug Administration granted emergency use authorization Friday for remdesivir, a medication researchers believe could treat patients diagnosed with COVID-19.
“We want to thank the collaborators that brought remdesivir to this point and many of our people that have been part of this, in fact, the caregivers,” Gilead CEO Daniel O’Day told reporters Friday.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.